Natco Pharma Ltd - Stock Price

As on2 Dec 2020
  • NSE : NATCOPHARM
  • BSE : 524816
  • ISIN CODE : INE987B01026
  • Industry : Pharmaceuticals & Drugs
  • House : Natco
Natco Pharma Ltd is not traded on BSE/NSE
908.70
-0.58 %-5.3
Previous Close 914.00
Day's Open 922.50
Bid Price (Qty) 0.00 (0)
Offer Price (Qty) 908.70 (341)
Day’s High - Low 922.50 - 904.00
52 Week Range 402.55 - 996
Volume Traded (in 000's) 177.06
Value traded (in Cr.) 16.09
PE Ratio (x) 41.18
M Cap (in Cr.)16561.65

Natco Pharma Ltd Stock Price

03/02/2017 | 15:19
  • Current Price8741.20
  • Open8735.15
  • High8748.25
  • Low8707.75
  • Prev. Close8734.25

Fundamentals

Parameter Values
Market Cap (Rs. in Cr.) 16561.65
Earning Per Share (EPS TTM) (Rs.) 22.08
Price To Earnings (P/E) Ratio 41.18
Book Value Per Share (Rs.) 221.95
Price/Book (MRQ) 4.10
Price/Earning (TTM) 32.28
ROCE (%) 14.85
PAT Margin 25.13
Dividend Yield 0.74
Face Value 2

Financial Summary

Parameter MAR 20 (`Mn.) MAR 19 (`Mn.) YoY %Change
Balance Sheet :
Share Capital364.00365.00-0.27
Total Non-Current Liabilities1178.00834.0041.25
Total Current Liabilities6853.007287.00-5.96
Total Liabilities45878.0043031.006.62
Total Non-Current Assets22622.0019559.0015.66
Currents Investments287.001487.00-80.70
Cash and Bank660.002795.00-76.39
Total Current Assets23256.0023472.00-0.92
Total Assets45878.0043031.006.62
Profit & Loss :
Gross Sales20582.0022846.00-9.91
Net Sales19150.0020945.00-8.57
Total Expenditure13324.0012997.002.52
Operating Profit6900.009250.00-25.41
Profit After Tax4581.006424.00-28.69
More from Financial Summary »

held by Mutual Fund Schemes

Scheme Holding(%)  
PGIM India Midcap Opp Fund-Reg(G)5.03
Mirae Asset Midcap Fund-Reg(G)3.84
Tata Large & Mid Cap Fund(G)3.55
SBI Healthcare Opp Fund-Reg(D)3.18
Baroda Mid-cap Fund(G)3.12
SBI Large & Midcap Fund-Reg(D)3.06
More from Held By MF Schemes »

News & Updates

  • There is no news in this stock

Peer Comparison

More Comparison »

Share Holdings

Description Percent of Share (%)
Promoters48.91
Non-Institution18.07
Mutual Funds/Uti9.26
Fi/Banks/Insurance0.19
FII0
Government0
More from Share holdings »

Corporate Information

Management Info

  • Chairman: V C Nannapaneni
  • Managing Director: V C Nannapaneni
  • Secretary: M Adinarayana

Registered Office

Address : Natco House,Road No 2,Banjara Hills, Hyderabad,
Telangana-500003 Tel : 040-23547532 Fax : 040-23548243 Email : investors@natcopharma.co.in / dasaradhi@natcopharma.co.in Website : www.natcopharma.co.in

Registars Details

Venture Capital & Corporate Investments Ltd
12-10-167,,MIG- 167,,Bharat Nagar Colony,Hyderabad

About Natco Pharma Ltd.

Natco Pharma Ltd. was incorporated in the year 1981. Its today's share price is 914. Its current market capitalisation stands at Rs 16561.65 Cr. In the latest quarter, company has reported Gross Sales of Rs. 20582 Cr and Total Income of Rs.20224 Cr. The company's management includes Sridhar Sankararaman, D Linga Rao, PSRK Prasad, Rajeev Nannapaneni, MUR Naidu, Leela Digumarti, DG Prasad, TV Rao, G S Murthy, V C Nannapaneni, V C Nannapaneni.

It is listed on the BSE with a BSE Code of 524816 , NSE with an NSE Symbol of NATCOPHARM and ISIN of INE987B01026. It's Registered office is at Natco House,Road No 2,Banjara HillsHyderabad-500003, Telangana. Their Registrars are ACC Ltd. It's auditors are Brahmayya & Co, BSR & Associates LLP, Walker Chandiok & Co LLP, Walker, Chandiok & Co, Walker, Chandiok & Co LLP

Latest News

close